Population-Based Analysis of Secular Trends in Age at Death in Trisomy 18 Syndrome in Japan from 1975 to 2016

Author:

Suto Maiko,Isayama Tetsuya,Morisaki NahoORCID

Abstract

<b><i>Introduction:</i></b> Despite changes in prenatal diagnostic methods and perceptions regarding the prognosis of and treatment options for patients with trisomy 18 syndrome, data on the secular changes in patient survival are limited. This study aimed to investigate the survival pattern for such patients. <b><i>Methods:</i></b> To investigate the general patient survival patterns, we used data from the vital statistics database of deaths in Japan from 1975 to 2016. We described demographic factors, such as sex, gestational age at delivery, and surgical history, for patients whose primary cause of death was trisomy 18 syndrome. <b><i>Results:</i></b> The proportions of deaths within 24 h of birth (4.0% in 1975–1980 to 21.9% in 2011–2016) and at age ≥1 year (8.9% in 1975–1980 to 17.7% in 2011–2016) increased. The median survival time was higher for females, infants born after 37 weeks of gestation, and those who received surgical intervention. The median survival time tripled among patients who received surgical intervention (61.5 days in 1995–2005 to 182.5 days in 2006–2016), and the proportion of such patients increased (from 3.8% in 1995 to 24.1% of the entire affected population in 2016). <b><i>Discussion/Conclusion:</i></b> In Japan, the median survival time of infants with trisomy 18 increased over time, and the proportion of death within 24 h and at ≥1 year increased. Greater acknowledgement of the possible benefits of surgical intervention likely led to the increased provision of interventions and contributed to the increased survival time.

Publisher

S. Karger AG

Subject

Developmental Biology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012 Oct 23;7:81.

2. Goel N, Morris JK, Tucker D, de Walle HEK, Bakker MK, Kancherla V, et al. Trisomy 13 and 18-prevalence and mortality: a multi-registry population based analysis. Am J Med Genet A. 2019 Dec;179(12):2382–92.

3. Kato E, Kitase Y, Tachibana T, Hattori T, Saito A, Muramatsu Y, et al. Factors related to survival discharge in trisomy 18: a retrospective multicenter study. Am J Med Genet A. 2019 Jul;179(7):1253–9.

4. Taira R, Inoue H, Sawano T, Fujiyoshi J, Ichimiya Y, Torio M, et al. Management of apnea in infants with trisomy 18. Dev Med Child Neurol. 2020 Jul;62(7):874–8.

5. Cooper DS, Riggs KW, Zafar F, Jacobs JP, Hill KD, Pasquali SK, et al. Cardiac surgery in patients with trisomy 13 and 18: an analysis of the society of thoracic surgeons congenital heart surgery database. J Am Heart Assoc. 2019 Jul 2;8(13):e012349.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3